Infection of totally implantable venous access devices: a review of the literature

F Pinelli, E Cecero, D Degl'Innocenti… - The journal of …, 2018 - journals.sagepub.com
Totally implantable venous access devices, or ports, are essential in the therapeutic
management of patients who require long-term intermittent intravenous therapy. Totally …

[HTML][HTML] Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial

K Taxbro, F Hammarskjöld, B Thelin, F Lewin… - British journal of …, 2019 - Elsevier
Background Centrally inserted totally implanted vascular access ports (PORTs) and
peripherally inserted central catheters (PICCs) are widely used for the administration of …

[HTML][HTML] Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: A systematic review and meta‐analysis

M Jiang, CL Li, CQ Pan, XW Cui, CF Dietrich - Journal of Thrombosis and …, 2020 - Elsevier
Background Totally implantable venous access ports (TIVAPs) for chemotherapy are
associated with venous thromboembolism (VTE). We aimed to quantify the incidence of …

An analysis of central venous catheter-related bloodstream infections in patients treated in a Swedish Covid-19 intensive care unit

P Lunnemar, K Taxbro… - SAGE Open …, 2024 - journals.sagepub.com
Background: Catheter-related bloodstream infection is a well-known, severe complication of
central venous catheter insertion. Studies that have evaluated the coronavirus disease 2019 …

[HTML][HTML] Complications from port-a-cath system implantation in adults with malignant tumors: A 10-year single-center retrospective study

Y Li, J Guo, Y Zhang, J Kong - Journal of interventional medicine, 2022 - Elsevier
Abstract Background Port-A-Cath systems (PCS) are safe and convenient devices for long-
term infusion in patients with malignant tumors. This study retrospectively analyzed the …

1000 Port-A-Cath® Placements by Subclavian Vein Approach: Single Surgeon Experience

S Mudan, A Giakoustidis, D Morrison, S Iosifidou… - World journal of …, 2015 - Springer
Introduction Totally implantable venous access ports are widely used for the administration
of chemotherapy in patients with cancer. Although there are several approaches to …

Complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: A retrospective cohort study

MJ Rieger, X Schenkel, I Dedic, T Brunn… - … Journal of Cancer, 2023 - Wiley Online Library
While implanted port catheters (“PORTs”) have historically been the standard device for
intravenous systemic anticancer therapy, the use of peripherally inserted central catheters …

Central venous access and the risk for thromboembolic events in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder …

H Rydell, Y Huge, V Eriksson, M Johansson… - Life, 2022 - mdpi.com
Thromboembolic events (TEE) are high-risk complications in patients undergoing
neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) for urothelial muscle …

[HTML][HTML] Patient-controlled sedation in port implantation (PACSPI 1)–A feasibility trial

S Seifert, K Taxbro, F Hammarskjöld - BJA open, 2022 - Elsevier
Background Central venous access is essential for the administration of chemotherapy and
frequent blood sampling in patients with cancer. The subcutaneous venous port is …

A survey of the current use of peripherally inserted central venous catheter (PICC) in Swedish oncology departments

E Johansson, F Hammarskjöld, D Lundberg… - Acta …, 2013 - Taylor & Francis
Full article: A survey of the current use of peripherally inserted central venous catheter (PICC) in
Swedish oncology departments Skip to Main Content Taylor and Francis Online homepage Taylor …